Consent2Randomize

"Consent2Randomize supports clinical trial enrollment by structuring patient intake, prescreening, referral review, and site handoff." That is how Consent2Randomize introduces itself. When AI engines look at it, they find little to work with. It scores 4.0 out of 10.

On its own pages the site does well on structured data describing the business, a clearly stated business identity and crawler access and the files AI engines look for. It is passable on a workable page structure. What holds it back is sitemaps and entity links AI can follow and credibility markers like credentials or reviews.

Off the page there is only faint evidence that only a handful of sites link to it. Beyond that, the domain does not yet read as established, AI engines do not yet recognise it as a distinct business, there is no press coverage to draw on, nobody is discussing it where AI engines look and it does not come up on Reddit. None of that can be fixed on the page: it has to be earned.

The site links to no social profiles, so there is nothing tying the brand to a wider presence.